BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 17526982)

  • 1. Serum resistin as a biological marker for coronary artery disease and restenosis in type 2 diabetic patients.
    On YK; Park HK; Hyon MS; Jeon ES
    Circ J; 2007 Jun; 71(6):868-73. PubMed ID: 17526982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel Biomarkers for Coronary Restenosis Occurrence After Drug-Eluting Stent Implantation in Patients With Diabetes Having Stable Coronary Artery Disease.
    Gabbasov Z; Kozlov S; Melnikov I; Byazrova S; Saburova O; Prokofieva L; Caprnda M; Curilla E; Gaspar L; Rodrigo L; Kruzliak P; Smirnov V
    Clin Appl Thromb Hemost; 2018 Nov; 24(8):1308-1314. PubMed ID: 29716394
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum resistin levels and cardiovascular events in patients undergoing percutaneous coronary intervention.
    Momiyama Y; Ohmori R; Uto-Kondo H; Tanaka N; Kato R; Taniguchi H; Arakawa K; Nakamura H; Ohsuzu F
    J Atheroscler Thromb; 2011; 18(2):108-14. PubMed ID: 21071880
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum resistin, adiposity and insulin resistance in Saudi women with type 2 diabetes mellitus.
    Al-Harithy RN; Al-Ghamdi S
    Ann Saudi Med; 2005; 25(4):283-7. PubMed ID: 16212119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin-3 is elevated in patients with coronary artery disease and predicts restenosis after percutaneous coronary intervention.
    Rudolph T; Schaps KP; Steven D; Koester R; Rudolph V; Berger J; Terres W; Meinertz T; Kaehler J
    Int J Cardiol; 2009 Mar; 132(3):392-7. PubMed ID: 18378332
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between preheparin lipoprotein lipase mass concentration in serum and bare metal stent restenosis.
    Hitsumoto T; Takahashi M; Iizuka T; Shirai K
    J Cardiol; 2006 Aug; 48(2):65-73. PubMed ID: 16948449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin resistance as a predictor for restenosis after coronary stenting.
    Nishio K; Fukui T; Tsunoda F; Kawamura K; Itoh S; Konno N; Ozawa K; Katagiri T
    Int J Cardiol; 2005 Aug; 103(2):128-34. PubMed ID: 16080969
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical outcomes after bare-metal stenting in diabetic patients with lesions carrying a low risk of restenosis.
    Woudstra P; Damman P; Beijk MA; Grundeken MJ; Harskamp RE; Koch KT; Henriques JP; Baan J; Vis MM; Piek JJ; Tijssen JG; de Winter RJ
    Catheter Cardiovasc Interv; 2013 Jan; 81(1):26-33. PubMed ID: 22511590
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of Insulin Resistance on Neointimal Tissue Proliferation after 2nd-Generation Drug-Eluting Stent Implantation.
    Komatsu T; Yaguchi I; Komatsu S; Nakahara S; Kobayashi S; Sakai Y; Taguchi I
    Tex Heart Inst J; 2015 Aug; 42(4):327-32. PubMed ID: 26413014
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resistin and adiponectin levels in subjects with coronary artery disease and type 2 diabetes.
    Yaturu S; Daberry RP; Rains J; Jain S
    Cytokine; 2006 May; 34(3-4):219-23. PubMed ID: 16822679
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Revascularization of coronary artery disease in diabetes mellitus].
    Wexberg P; Weidinger F
    Wien Med Wochenschr; 2010 Jan; 160(1-2):40-3. PubMed ID: 20229160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adiponectin and insulin resistance are related to restenosis and overall new PCI in subjects with normal glucose tolerance: the prospective AIRE Study.
    Sasso FC; Pafundi PC; Marfella R; Calabrò P; Piscione F; Furbatto F; Esposito G; Galiero R; Gragnano F; Rinaldi L; Salvatore T; D'Amico M; Adinolfi LE; Sardu C
    Cardiovasc Diabetol; 2019 Mar; 18(1):24. PubMed ID: 30832662
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical and angiographic outcome in coronary artery disease patients with type-II diabetes mellitus undergoing elective bare-metal stenting or drug-eluting stenting].
    Qiao SB; Hou Q; Xu B; Chen J; Liu HB; Yang YJ; Wu YJ; Yuan JQ; Wu Y; Dai J; You SJ; Ma WH; Zhang P; Gao Z; Dou KF; Qiu H; Mu CW; Chen JL; Gao RL
    Zhonghua Xin Xue Guan Bing Za Zhi; 2007 Jun; 35(6):523-6. PubMed ID: 17711711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RELATIONSHIP OF SERUM RESISTIN WITH INSULIN RESISTANCE AND OBESITY.
    Zaidi SI; Shirwany TA
    J Ayub Med Coll Abbottabad; 2015; 27(3):552-5. PubMed ID: 26721005
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical and angiographic predictors of restenosis after bare metal stent deployment in coronary artery disease patients complicated with diabetes].
    Jin ZN; Chen YD; Lü SZ; Song XT; Zhu HG; Li H
    Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Dec; 34(12):1093-6. PubMed ID: 17274899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A single center investigation of bare-metal or drug-eluting stent restenosis from 1633 consecutive Chinese Han ethnic patients.
    Xu B; Li JJ; Yang YJ; Ma WH; Chen JL; Qiao SB; Qin XW; Yao M; Liu HB; Wu YJ; Yuan JQ; Chen J; You SJ; Dai J; Xia R; Gao RL
    Chin Med J (Engl); 2006 Apr; 119(7):533-8. PubMed ID: 16620692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma levels of C-reactive protein and interleukin-10 predict late coronary in-stent restenosis 6 months after elective stenting.
    Zurakowski A; Wojakowski W; Dzielski T; Milewski K; Gościńska-Bis K; Tendera M; Buszman P
    Kardiol Pol; 2009 Jun; 67(6):623-30. PubMed ID: 19618318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preventative effects of rosiglitazone on restenosis after coronary stent implantation in patients with type 2 diabetes.
    Choi D; Kim SK; Choi SH; Ko YG; Ahn CW; Jang Y; Lim SK; Lee HC; Cha BS
    Diabetes Care; 2004 Nov; 27(11):2654-60. PubMed ID: 15505001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiographic patterns of drug-eluting stent restenosis after treatment with drug-coated balloon versus balloon angioplasty: Late lumen loss subgroup analyses of the PEPCAD-DES study.
    Rittger H; Wöhrle J; Brachmann J; Hohenforst-Schmidt W; Schlundt C; Lonke S; von Cranach M; Markovic S; Achenbach S; Waliszewski M
    Catheter Cardiovasc Interv; 2016 Oct; 88(4):529-534. PubMed ID: 26893095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adipocytokines, insulin resistance, and coronary atherosclerosis in rheumatoid arthritis.
    Rho YH; Chung CP; Solus JF; Raggi P; Oeser A; Gebretsadik T; Shintani A; Stein CM
    Arthritis Rheum; 2010 May; 62(5):1259-64. PubMed ID: 20213808
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.